Development and characteristics of resistance to the HER family tyrosine kinase inhibitor AZD8931

Valerie Brunton; Helen Creedon; Morwenna Muir; Kenneth Macleod; Teresa Klinowska; Adam Byron

doi:10.1016/S0959-8049(14)70617-3

Development and characteristics of resistance to the HER family tyrosine kinase inhibitor AZD8931

Valerie Brunton, Helen Creedon, Morwenna Muir, Kenneth Macleod, Teresa Klinowska, Adam Byron

Research output: Contribution to conference › Abstract

Original language	English
Pages	160
DOIs	https://doi.org/10.1016/S0959-8049(14)70617-3
Publication status	Published - 21 Nov 2014

Access to Document

10.1016/S0959-8049(14)70617-3

Cite this

@conference{5ec62401ca074620b222ff551172010d,

title = "Development and characteristics of resistance to the HER family tyrosine kinase inhibitor AZD8931",

author = "Valerie Brunton and Helen Creedon and Morwenna Muir and Kenneth Macleod and Teresa Klinowska and Adam Byron",

note = "Reference: European Journal of Cancer. 50, p. 160 (2014). Conference: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.",

year = "2014",

month = nov,

day = "21",

doi = "10.1016/S0959-8049(14)70617-3",

language = "English",

pages = "160",

}

TY - CONF

T1 - Development and characteristics of resistance to the HER family tyrosine kinase inhibitor AZD8931

AU - Brunton, Valerie

AU - Creedon, Helen

AU - Muir, Morwenna

AU - Macleod, Kenneth

AU - Klinowska, Teresa

AU - Byron, Adam

N1 - Reference: European Journal of Cancer. 50, p. 160 (2014). Conference: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.

PY - 2014/11/21

Y1 - 2014/11/21

U2 - 10.1016/S0959-8049(14)70617-3

DO - 10.1016/S0959-8049(14)70617-3

M3 - Abstract

SP - 160

ER -